Diclofenac prodrugs nanoparticles: An alternative and efficient treatment for rheumatoid arthritis?

This publication has 26 references indexed in Scilit:

• Liposomal corticosteroids for the treatment of inflammatory disorders and cancer
  Journal of Controlled Release, 2014
• A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity
  Proceedings of the National Academy of Sciences, 2014
• Nanomedicines for Inflammatory Arthritis: Head-to-Head Comparison of Glucocorticoid-Containing Polymers, Micelles, and Liposomes
  ACS Nano, 2013
• Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture
  Inflammopharmacology, 2013
• Socioeconomic Burden of Immune-Mediated Inflammatory Diseases -- Focusing on Work Productivity and Disability
  The Journal of Rheumatology, 2011
• Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
  Annals of the Rheumatic Diseases, 2011
• The impact of rheumatoid arthritis on the burden of disease in urban China
  Journal of Medical Economics, 2011
• Thermodynamic and Kinetic Stability of DSPE-PEG(2000) Micelles in the Presence of Bovine Serum Albumin
  The Journal of Physical Chemistry B, 2010
• Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study
  Rheumatology, 2006
• Physicochemical Properties of Dexamethasone Palmitate, a High Fatty Acid Ester of an Anti-inflammatory Drug: Polymorphism and Crystal Structure
  Journal of Pharmaceutical Sciences, 1989